Abstract: This invention relates to supported metallocene catalyst systems for polymerization, the catalyst systems comprising asymmetrically substituted indenyl groups, high surface area supports, and aluminoxane activators. This invention also relates to methods for polymerizing olefins, including methods for producing isotactic polypropylene.

Abstract: This invention relates to supported metallocene catalyst systems for polymerization, the catalyst systems comprising asymmetrically substituted indenyl groups, high surface area supports, and aluminoxane activators. This invention also relates to methods for polymerizing olefins, including methods for producing isotactic polypropylene.

Abstract: This invention relates to high porosity (?15%) and/or low pore diameter (PD<165 ?m) propylene polymers and propylene polymerization processes using single site catalyst systems with supports having high surface area (SA?400 m2/g), low pore volume (PV?2 mL/g), a specific mean pore diameter range (PD=1-20 nm), and high average particle size (PS?30 ?m).

Abstract: Catalyst systems and methods for making and using the same are provided. A method for forming a polymer catalyst includes reacting a bromoketone compound with an aryl amine compound to form an amide compound. The amide compound is reacted with an ethylene diamine compound, to form a terminal primary amine compound. The terminal primary amine compound is reacted with a bromoaryl compound to form a ligand.

Abstract: An ethylene copolymer, a Group 4 transition metal catalyst compound, and methods for polymerization using such a compound, said compound represented by the formula: (L)p(R?)zT(Cp)(A)MX2, where M is a Group 4 metal; z is 0 to 8; p is 1 to 3; X is an anionic leaving group; T is a bridging group; R1 to R4 are hydrogen, a hydrocarbyl group, a substituted hydrocarbyl group, aryl group, substituted aryl group, or a heteroatom-containing group (where adjacent R groups can form rings); R? is hydrogen, a C1 to C10 alkyl group, a C6 to C24 aryl group, or a C7 to C40 alkylaryl group; and L is a heteroatom or heteroatom-containing group bound to T, Cp is a cyclopentadienyl ring substituted with 0 to 4 substituent groups (where adjacent groups can form C4 to C20 rings); A is Cp or (JS?z*-1-y), where J is a Group 15 or 16 element; S? is a hydrocarbyl, substituted hydrocarbyl, or heteroatom; z* is 2 or 3, and y is 0 or 1, is provided.

Abstract: A method for protecting a phenol group on a precursor compound is provided. The method includes reacting the phenol group with dihydropyran in an acid catalyzed protection reaction and quenching the protection reaction with a strong base within less than about 60 seconds to form a protected precursor compound.

Abstract: A system for determining the concentration of an analyte in at least one body fluid in body tissue comprises an infrared light source, a body tissue interface, a detector, and a central processing unit. The body tissue interface is adapted to contact body tissue and to deliver light from the infrared light source to the contacted body tissue. The detector is adapted to receive spectral information corresponding to infrared light transmitted through the portion of body tissue being analyzed and to convert the received spectral information into an electrical signal indicative of the received spectral information. The central processing unit is adapted to compare the electrical signal to an algorithm built upon correlation with the analyte in body fluid, the algorithm adapted to convert the received spectral information into the concentration of the analyte in at least one body fluid.

Abstract: This invention relates to high porosity (?15%) and/or low pore diameter (PD<165 ?m) propylene polymers and propylene polymerization processes using single site catalyst systems with supports having high surface area (SA?400 m2/g), low pore volume (PV?2 mL/g), a specific mean pore diameter range (PD=1-20 nm), and high average particle size (PS?30 ?m).

Abstract: A method for protecting a phenol group on a precursor compound is provided. The method includes reacting the phenol group with dihydropyran in an acid catalyzed protection reaction and quenching the protection reaction with a strong base within less than about 60 seconds to form a protected precursor compound.

Abstract: Catalyst systems and methods for making and using the same are provided. A method for forming a polymer catalyst includes reacting a bromoketone compound with an aryl amine compound to form an amide compound. The amide compound is reacted with an ethylene diamine compound, to form a terminal primary amine compound. The terminal primary amine compound is reacted with a bromoaryl compound to form a ligand.

Abstract: A door structure is provided having two outer dampening layers, each outer dampening layer having a base surface and a damping surface, and an inner compartmentalized layer adjacent to the damping surfaces of the two outer dampening layers, the inner compartmentalized layer includes at least two compartments, wherein the damping surfaces of the two outer dampening layers are substantially unconstrained relative to the inner compartmentalized layer such that the damping surfaces are deformable.

Abstract: An ethylene copolymer, a Group 4 transition metal catalyst compound, and methods for polymerization using such a compound, said compound represented by the formula: (L)p(R?)zT(Cp)(A)MX2, where M is a Group 4 metal; z is 0 to 8; p is 1 to 3; X is an anionic leaving group; T is a bridging group; R1 to R4 are hydrogen, a hydrocarbyl group, a substituted hydrocarbyl group, aryl group, substituted aryl group, or a heteroatom-containing group (where adjacent R groups can form rings); R? is hydrogen, a C1 to C10 alkyl group, a C6 to C24 aryl group, or a C7 to C40 alkylaryl group; and L is a heteroatom or heteroatom-containing group bound to T, Cp is a cyclopentadienyl ring substituted with 0 to 4 substituent groups (where adjacent groups can form C4 to C20 rings); A is Cp or (JS?z*-1-y), where J is a Group 15 or 16 element; S? is a hydrocarbyl, substituted hydrocarbyl, or heteroatom; z* is 2 or 3, and y is 0 or 1, is provided.

Abstract: The present invention provides isolated or genetically modified strains of microorganisms that display enhanced resistance to acetate as a result of increased expression of a sodium proton antiporter. The present invention also provides methods for producing such microbial strains, as well as related promoter sequences and expression vectors. Further, the present invention provides methods of producing alcohol from biomass materials by using microorganisms with enhanced resistance to acetate.

Abstract: The present invention provides genetically modified strains of microorganisms that display enhanced tolerance to stress and/or inhibitors such as sodium acetate and vanillin. The enhanced tolerance can be achieved by increasing the expression of a protein of the Sm-like superfamily such as a bacterial Hfq protein and a fungal Sm or Lsm protein. Further, the present invention provides methods of producing alcohol from biomass materials by using the genetically modified microorganisms of the present invention.

Abstract: A door structure is provided having two outer dampening layers, each outer dampening layer having a base surface and a damping surface, and an inner compartmentalized layer adjacent to the damping surfaces of the two outer dampening layers, the inner compartmentalized layer includes at least two compartments, wherein the damping surfaces of the two outer dampening layers are substantially unconstrained relative to the inner compartmentalized layer such that the damping surfaces are deformable.

Abstract: A system for determining the concentration of an analyte in at least one body fluid in body tissue comprises an infrared light source, a body tissue interface, a detector, and a central processing unit. The body tissue interface is adapted to contact body tissue and to deliver light from the infrared light source to the contacted body tissue. The detector is adapted to receive spectral information corresponding to infrared light transmitted through the portion of body tissue being analyzed and to convert the received spectral information into an electrical signal indicative of the received spectral information. The central processing unit is adapted to compare the electrical signal to an algorithm built upon correlation with the analyte in body fluid, the algorithm adapted to convert the received spectral information into the concentration of the analyte in at least one body fluid.

Abstract: A system for determining the concentration of an analyte in at least one body fluid in body tissue comprises an infrared light source, a body tissue interface, a detector, and a central processing unit. The body tissue interface is adapted to contact body tissue and to deliver light from the infrared light source to the contacted body tissue. The detector is adapted to receive spectral information corresponding to infrared light transmitted through the portion of body tissue being analyzed and to convert the received spectral information into an electrical signal indicative of the received spectral information. The central processing unit is adapted to compare the electrical signal to an algorithm built upon correlation with the analyte in body fluid, the algorithm adapted to convert the received spectral information into the concentration of the analyte in at least one body fluid.

Abstract: The present invention provides genetically modified strains of microorganisms that display enhanced tolerance to stress and/or inhibitors such as sodium acetate and vanillin. The enhanced tolerance can be achieved by increasing the expression of a protein of the Sm-like superfamily such as a bacterial Hfq protein and a fungal Sm or Lsm protein. Further, the present invention provides methods of producing alcohol from biomass materials by using the genetically modified microorganisms of the present invention.

Abstract: The invention relates to olefin oligomerization methods and methods for reducing/inhibiting fouling in olefin oligomerization reactions comprising: contacting, in an oligomerization reactor (e.g., under oligomerization conditions), an alpha-olefin feed, a catalyst having an olefin selectivity of at least 90 mol % to a desired oligomerization product, a polymer anti-foulant, and optionally a diluent; selectively producing an effluent comprising the desired oligomerization product, unreacted olefin, and alpha-olefin-based polymer byproduct that causes fouling. The amount of polymer anti-foulant can be chosen to limit fouling to ?20 g/kg desired oligomerization product, to remediate ?3 grams fouled polymer/kg desired oligomerization product, and/or to reduce/inhibit polymer fouling by ?10% over a selective oligomerization with substantially no added polymer anti-foulant. Advantageously, desired oligomerization product so obtained can also be polymerized/copolymerized with an alpha-olefin such as ethylene.

Abstract: A system for determining the concentration of an analyte in at least one body fluid in body tissue comprises an infrared light source, a body tissue interface, a detector, and a central processing unit. The body tissue interface is adapted to contact body tissue and to deliver light from the infrared light source to the contacted body tissue. The detector is adapted to receive spectral information corresponding to infrared light transmitted through the portion of body tissue being analyzed and to convert the received spectral information into an electrical signal indicative of the received spectral information. The central processing unit is adapted to compare the electrical signal to an algorithm built upon correlation with the analyte in body fluid, the algorithm adapted to convert the received spectral information into the concentration of the analyte in at least one body fluid.